Pages that link to "Q28268561"

The following pages link to The human gut microbiome: current knowledge, challenges, and future directions (Q28268561):

Displaying 50 items.

• Modeling-Enabled Systems Nutritional Immunology (Q26766623) (← links)
• The Intestinal Microbiota in Inflammatory Bowel Disease (Q26795705) (← links)
• Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection (Q27009228) (← links)
• Gut Microbiota-brain Axis (Q28066767) (← links)
• A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis (Q28069331) (← links)
• Human Microbiome: When a Friend Becomes an Enemy (Q28085629) (← links)
• Radiation enteropathy--pathogenesis, treatment and prevention (Q28237189) (← links)
• The human gut microbiota and virome: Potential therapeutic implications (Q28266057) (← links)
• Optimizing methods and dodging pitfalls in microbiome research (Q29994526) (← links)
• Blastocystis: how do specific diets and human gut microbiota affect its development and pathogenicity? (Q30235155) (← links)
• The microbiome in inflammatory bowel disease: current status and the future ahead (Q33664898) (← links)
• The microbiota in inflammatory bowel disease: current and therapeutic insights (Q33806817) (← links)
• Friends with social benefits: host-microbe interactions as a driver of brain evolution and development? (Q34419563) (← links)
• The health advantage of a vegan diet: exploring the gut microbiota connection (Q34446013) (← links)
• Unique secreted-surface protein complex of Lactobacillus rhamnosus, identified by phage display. (Q34509256) (← links)
• The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. (Q34965829) (← links)
• Acquisition of oral microbes and associated systemic responses of newborn nonhuman primates (Q35029127) (← links)
• Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes (Q35055599) (← links)
• Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota (Q35069150) (← links)
• The newest "omics"--metagenomics and metabolomics--enter the battle against the neglected tropical diseases (Q35077991) (← links)
• The intestinal microbiome in type 1 diabetes (Q35120481) (← links)
• Immunology of inflammatory bowel disease and molecular targets for biologics (Q35222593) (← links)
• Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology? (Q35492374) (← links)
• Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. (Q35602080) (← links)
• Effect of Probiotics/Prebiotics on Cattle Health and Productivity (Q35640340) (← links)
• Selective enrichment of commensal gut bacteria protects against Citrobacter rodentium-induced colitis (Q35661681) (← links)
• Potential role of the intestinal microbiota in programming health and disease (Q35691572) (← links)
• Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn's Disease. (Q35730471) (← links)
• Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia. (Q35750928) (← links)
• High-throughput sequencing reveals the core gut microbiome of Bar-headed goose (Anser indicus) in different wintering areas in Tibet (Q35913997) (← links)
• Characterization of Intestinal Microbiomes of Hirschsprung's Disease Patients with or without Enterocolitis Using Illumina-MiSeq High-Throughput Sequencing (Q36125131) (← links)
• Antibiotics, gut microbiota, environment in early life and type 1 diabetes. (Q36277657) (← links)
• Frequency and distribution of FCN2 and FCN3 functional variants among MBL2 genotypes (Q36828752) (← links)
• Immune mediated shaping of microflora community composition depends on barrier site (Q37452507) (← links)
• Bacterial colonization and intestinal mucosal barrier development (Q38254145) (← links)
• The management of autoimmunity in patients with cholestatic liver diseases (Q38622370) (← links)
• Gut microbiome diversity influenced more by the Westernized dietary regime than the body mass index as assessed using effect size statistic. (Q38693558) (← links)
• Novel Strategies for Applied Metagenomics. (Q38723919) (← links)
• Oral biofilms: molecular analysis, challenges, and future prospects in dental diagnostics (Q39418843) (← links)
• The Gut Microbiome in the NOD Mouse. (Q39873963) (← links)
• Consequences of Increases in Antibiotic Resistance Pattern on Outcome of Pancreatic Resection for Cancer. (Q40133635) (← links)
• Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention. (Q40780875) (← links)
• The Human Microbiome and the Missing Heritability Problem. (Q42206776) (← links)
• Potential role of gastrointestinal microbiota composition in prostate cancer risk. (Q42908744) (← links)
• Cultivation strategies for growth of uncultivated bacteria (Q43132778) (← links)
• A comparison of the efficiency of five different commercial DNA extraction kits for extraction of DNA from faecal samples (Q45811666) (← links)
• Microbiota Replacement Therapies: Innovation in Gastrointestinal Care (Q46274429) (← links)
• Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. (Q46284784) (← links)
• Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease (Q47952446) (← links)
• Western Indian Rural Gut Microbial Diversity in Extreme Prakriti Endo-Phenotypes Reveals Signature Microbes (Q50330914) (← links)